Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's disease
- 1 December 2000
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 102, 60-67
- https://doi.org/10.1034/j.1600-0404.2000.00309.x
Abstract
The extracellular deposition of amyloid beta-peptide (Aβ) in the form of cerebrovascular amyloid and extracellular plaques is one of the major neuropathological manifestations of Alzheimer's disease ...Keywords
This publication has 32 references indexed in Scilit:
- The Origins of Alzheimer DiseaseJAMA, 2000
- Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive DeclineJAMA, 2000
- Pinning down phosphorylated tauNature, 1999
- Alzheimer's Disease--Genotypes, Phenotype, and TreatmentsScience, 1997
- Cholinesterase Inhibitors as Therapy in Alzheimer’s Disease: Benefit to Risk Considerations in Clinical ApplicationPublished by Springer Nature ,1997
- Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's DiseaseJournal of Neurochemistry, 1995
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentAnnals of Neurology, 1991
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978